Subpopulation

All patients with RMS

Control group

Р

Leu8+ CD4+ (%)

17.6 ± 3.6

(n = 10)

33.5 ± 4.7

(n = 10)

0.015

Leu8+ CD4+ (abs.)

7.2 ± 1.3

(n = 6)

5.3 ± 1.1

(n = 10)

0.047